Risk factors for monoclonal gammopathy of undetermined significance: a systematic review

被引:21
作者
Castaneda-Avila, Maira A. [1 ]
Ulbricht, Christine M. [1 ]
Epstein, Mara Meyer [1 ,2 ,3 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Populat & Quantitat Hlth Sci, Worcester, MA USA
[2] Univ Massachusetts, Sch Med, Meyers Primary Care Inst, 365 Plantat St,Suite 100, Worcester, MA 01605 USA
[3] Univ Massachusetts, Sch Med, Dept Med, 365 Plantat St,Suite 100, Worcester, MA 01605 USA
基金
美国国家卫生研究院;
关键词
MGUS; Risk factors; Systematic review; PRECEDES MULTIPLE-MYELOMA; SIGNIFICANCE MGUS; PRIOR AUTOIMMUNE; POOLED ANALYSIS; PREVALENCE; OBESITY; MORTALITY; CANCER; WHITE; METAANALYSIS;
D O I
10.1007/s00277-021-04400-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monoclonal gammopathy of undetermined significance (MGUS), precursor of multiple myeloma, is an asymptomatic plasma cell disorder that overproduces serum monoclonal protein. Older age, male sex, black race, and family history of MGUS increase the risk of MGUS, yet other risk factors are known. We systematically reviewed observational epidemiological studies that examined sociodemographic, clinical, and behavioral risk factors for the development of MGUS. The protocol for this study was registered on the PROSPERO registry for systematic reviews. We identified epidemiological studies from PubMed and Scopus. Articles were limited to those written in English and published before February 2019. Five case-control and three cohort studies were eligible for data extraction. Studies evaluating factors associated with MGUS risk are limited, with conflicting conclusions regarding risk associated with obesity. Despite the limited research, a significant elevated risk for being diagnosed with MGUS was associated with several specific prior infections, inflammatory disorders, and smoking. The sparse existing literature suggests an increased risk of MGUS associated with several risk factors related to immune function. Further research is needed to explore the potential mechanisms underlying the development of MGUS and to confirm risk factors, both modifiable and non-modifiable.
引用
收藏
页码:855 / 863
页数:9
相关论文
共 50 条
  • [41] Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance
    Sverrisdottir, Ingigerdur
    Thorsteinsdottir, Sigrun
    Rognvaldsson, Saemundur
    Aspelund, Thor
    Vidarsson, Brynjar
    Onundarson, Pall Torfi
    Agnarsson, Bjarni A.
    Sigurdardottir, Margret
    Thorsteinsdottir, Ingunn
    Sveinsdottir, Signy Vala
    Palmason, Robert
    Olafsson, Isleifur
    Sigurdsson, Fridbjorn
    Thordardottir, Asdis Rosa
    Eythorsson, Elias
    Jonsson, Asbjorn
    Palsson, Runolfur
    Indridason, Olafur Skuli
    Gislason, Gauti Kjartan
    Olafsson, Andri
    Sigurdsson, Jon
    Steingrimsdottir, Hlif
    Einarsson Long, Thorir
    Hultcrantz, Malin
    Durie, Brian G. M.
    Harding, Stephen
    Landgren, Ola
    Kristinsson, Sigurdur Yngvi
    Love, Thorvardur Jon
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (06) : 711 - 718
  • [42] IgD monoclonal gammopathy of undetermined significance
    Kinoshita, T
    Nagai, H
    Murate, T
    Saito, H
    Fukatsu, T
    Hotta, T
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1997, 65 (02) : 169 - 172
  • [43] Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects
    Seth, Shivani
    Zanwar, Saurabh
    Vu, Linh
    Kapoor, Prashant
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (02) : 45 - 55
  • [44] Monoclonal gammopathy of undetermined significance causing large vessel vasculitis
    Alcorn, Edward George
    Floyd, Lauren
    Dhaygude, Ajay
    BMJ CASE REPORTS, 2022, 15 (06)
  • [45] Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance
    Pasqualetti, P
    Casale, R
    BIOMEDICINE & PHARMACOTHERAPY, 1997, 51 (02) : 74 - 78
  • [46] Socioeconomic Position is Positively Associated with Monoclonal Gammopathy of Undetermined Significance in a Population-based Cohort Study
    Schmidt, Boerge
    Debold, Elisabeth
    Frank, Mirjam
    Arendt, Marina
    Dragano, Nico
    Duerig, Jan
    Duehrsen, Ulrich
    Moebus, Susanne
    Erbel, Raimund
    Joeckel, Karl-Heinz
    Eisele, Lewin
    ANNALS OF HEMATOLOGY, 2019, 98 (12) : 2761 - 2767
  • [47] Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population-based cohort study
    Rognvaldsson, Saemundur
    Aspelund, Thor
    Thorsteinsdottir, Sigrun
    Turesson, Ingemar
    Bjorkholm, Magnus
    Landgren, Ola
    Kristinsson, Sigurour Yngvi
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (01) : 137 - 144
  • [48] Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota
    Kleinstern, Geffen
    Larson, Dirk R.
    Allmer, Cristine
    Norman, Aaron D.
    Muntifering, Grace
    Sinnwell, Jason
    Visram, Alissa
    Rajkumar, Vincent
    Dispenzieri, Angela
    Kyle, Robert A.
    Slager, Susan L.
    Kumar, Shaji
    Vachon, Celine M.
    BLOOD CANCER JOURNAL, 2022, 12 (04)
  • [49] Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China
    Xu, Anping
    Guo, Tong
    Zhang, Shuping
    Luo, Houlong
    Shen, Mengxue
    Ye, Yinghui
    Ji, Ling
    HEMATOLOGY, 2024, 29 (01)
  • [50] Monoclonal gammopathy of undetermined significance and Waldenstrom's macroglobulinemia
    Mailankody, Sham
    Landgren, Ola
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2016, 29 (02) : 187 - 193